Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Benchmark Holdings Plc Director's Dealing 2020

Feb 21, 2020

6035_dirs_2020-02-21_5eac7250-b26c-44a9-a0ac-4a52a0aeb956.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7566D

Benchmark Holdings PLC

21 February 2020

21 February 2020

BENCHMARK HOLDINGS PLC

("Benchmark" or the "Company" or the "Group")

PDMR Shareholding

The Company announces, further to the announcement made on 30 January 2020, that the following persons discharging managerial responsibilities (PDMRs) for the purposes of Article 19 of the Market Abuse Regulation (EU 596/2014) participated in the Placing and/or Open Offer (the "Fundraising").

Name Number of existing Ordinary Shares Number of Placing Shares subscribed for Number of Open Offer shares subscribed for and awarded Number of Ordinary Shares now held Percentage of Enlarged Share Capital now held
Peter George 1,000,000 1,250,000 68,219 2,318,219 0.35%
Septima Maguire - 250,000 - 250,000 0.04%
Susan Searle 98,125 100,000 - 198,125 0.03%
Hugo Wahnish 275,000 75,000 - 350,000 0.05%
Yngve Myhre 400,000 200,000 - 600,000 0.09%
Kevin Quinn 60,929 25,000 - 85,929 0.01%
Alex Raeber 200,000 - 7,658 207,658 0.03%

Notification and public disclosure of transactions by persons discharging managerial responsibilities.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter George (Executive Chairman)

Septima Maguire (Chief Financial Officer)

Susan Searle (Non Executive Director)

Hugo Wahnish (Non Executive Director)

Yngve Myhre (Non Executive Director)

Kevin Quinn (Non Executive Director)

Alex Raeber (Chief Scientific Officer)

2

Reason for the notification

a)

Position/status

See 1(a) above

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Benchmark Holdings plc

b)

LEI

2138001UQHM4VZGXUJ19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares

ISIN: GB00BGHPT808

b)

Nature of the transaction

Subscription for new ordinary shares pursuant to the Placing and/or Open Offer

c)

Price(s) and volume(s)

Director/ PDMR Price(s) Volume(s)
Peter George

Septima Maguire

Susan Searle

Hugo Wahnish

Yngve Myhre

Kevin Quinn

Alex Raeber
40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence
1,318,219

250,000

100,000

75,000

200,000

25,000

7,658

d)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

Director/ PDMR Aggregated volume Price(s) Aggregated total
Peter George

Septima Maguire

Susan Searle

Hugo Wahnish

Yngve Myhre

Kevin Quinn

Alex Raeber
1,318,219

250,000

100,000

75,000

200,000

25,000

7,658
40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence
£527,287.60

£100,000.00

£40,000.00

£30,000.00

£80,000.00

£10,000.00

£3,063.20

e)

Date of the transaction

19 February 2020

f)

Place of the transaction

London Stock Exchange, AIM

-Ends-

Benchmark Holdings plc Tel: 020 3696 0630
Ivonne Cantu, Investor Relations Director
Rachel Aninakwah, Communications
Numis Tel: 020 7260 1000
Freddie Barnfield, Duncan Monteith (NOMAD)
James Black (Corporate Broking)
MHP
Katie Hunt / Reg Hoare /Alistair de Kare-Silver Tel: 020 3128 8742                                 

[email protected]

About Benchmark

Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFLFSIFSILFII